Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.39 |
| ▸ | DAO | P14920 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2007922 | 0.83 | CA2 (0.44) | CA2DAOCA12CA1CA3 | |
| SCHEMBL16288940 | 0.76 | DAO (0.40) | CA2DAO | |
| SCHEMBL11475698 | 0.74 | DAO (0.39) | CA2DAO | |
| SCHEMBL2567368 | 0.74 | DAO (0.43) | CA2DAO | |
| Hydrochloric Acid SCHEMBL31601091 | 0.73 | DAO (0.35) | CA2DAOCA12CA1CA3 | |
| SCHEMBL2173431 | 0.72 | DAO (0.42) | CA2DAO | |
| Lithium Ion SCHEMBL2173434 | 0.72 | LMNA (0.42) | CA2DAO | |
| SCHEMBL23569064 | 0.72 | IKBKB (0.34) | CA2CA12CA1CA9 | |
| SCHEMBL8493663 | 0.68 | HTR6 (0.54) | CA2DAO | |
| SCHEMBL23569221 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021123237-A1 | 2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE | Oxford Drug Design Limited (GB) | 2021-06-24 | — | — | WO | disclosed |